S. Kaptoge

Statistics and Probability · 2005–2021

A researcher in the Science corpus: 25 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Kaptoge trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Julian P. T. Higgins
  2. P. Ridker
  3. G. Moneta
  4. S. Thompson
  5. John Danesh

Who trusts S. Kaptoge overall

  1. P. Ridker
  2. Massimo F. Piepoli
  3. Peter Libby
  4. C. Boutari
  5. N. Wong
  6. R. Shephard

Papers from S. Kaptoge's perspective

Ordered by how strongly the researchers S. Kaptoge trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention… (Circulation)
  2. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. (Circulation)
  3. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study (Circulation)
  4. Mendelian randomization: prospects, potentials, and limitations. (International Journal of Epidemiology)
  5. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. (New England Journal of Medicine)
  6. Inflammatory markers and the risk of coronary heart disease in men and women. (New England Journal of Medicine)
  7. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians.
  8. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
  9. Risk scoring for the primary prevention of cardiovascular disease
  10. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. (Arthritis & Rheumatism)

Their papers